Indo Us Bio-Tech Limited (BOM:541304)
127.35
-4.55 (-3.45%)
At close: Feb 12, 2026
Indo Us Bio-Tech Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Cash & Equivalents | - | 2.48 | 10.98 | 1.9 | 0.49 | 1.34 |
Cash & Short-Term Investments | 5.88 | 2.48 | 10.98 | 1.9 | 0.49 | 1.34 |
Cash Growth | -43.59% | -77.44% | 479.59% | 285.03% | -63.38% | -32.93% |
Accounts Receivable | - | 150.01 | 190.45 | 247.42 | 205.47 | 247.06 |
Other Receivables | - | 0.01 | 0.01 | 0.9 | - | - |
Receivables | - | 150.02 | 190.46 | 248.32 | 205.47 | 247.06 |
Inventory | - | 706.86 | 517.35 | 269.13 | 233.57 | 118.8 |
Prepaid Expenses | - | 0.37 | 0.34 | 0.16 | 0.47 | 0.55 |
Other Current Assets | - | 7.53 | 11.77 | 79.58 | 28.38 | 13.6 |
Total Current Assets | - | 867.27 | 730.91 | 599.09 | 468.38 | 381.35 |
Property, Plant & Equipment | - | 102.34 | 104.7 | 87.35 | 78.77 | 43.56 |
Long-Term Deferred Tax Assets | - | 6.96 | 6.59 | 5.85 | 4.2 | 2.6 |
Long-Term Deferred Charges | - | - | - | - | - | 0.14 |
Other Long-Term Assets | - | 1.86 | 2.36 | 2.36 | 4.82 | 9.42 |
Total Assets | - | 978.43 | 844.56 | 694.65 | 556.16 | 437.07 |
Accounts Payable | - | 11.62 | 43.88 | 13.96 | 21.57 | 89.4 |
Accrued Expenses | - | 3.46 | 2.57 | 2 | 2.58 | 2.54 |
Short-Term Debt | - | 103.74 | 103.84 | 83.74 | 68.23 | 71.87 |
Current Portion of Long-Term Debt | - | 15.28 | 11.39 | 15.21 | 22.83 | 9.27 |
Current Income Taxes Payable | - | 3 | 3.52 | 0.97 | 0.97 | 0.75 |
Other Current Liabilities | - | 26.29 | 23.43 | 7.05 | 6.66 | 7.09 |
Total Current Liabilities | - | 163.39 | 188.63 | 122.93 | 122.84 | 180.92 |
Long-Term Debt | - | 29.34 | 28.02 | 17.05 | 37.33 | 34.53 |
Pension & Post-Retirement Benefits | - | 0.51 | 0.44 | 0.43 | 0.36 | 0.34 |
Other Long-Term Liabilities | - | - | -0 | 9.29 | 10.55 | 7.86 |
Total Liabilities | - | 193.24 | 217.09 | 149.69 | 171.09 | 223.65 |
Common Stock | - | 200.52 | 200.52 | 100.26 | 91.67 | 60.68 |
Additional Paid-In Capital | - | 221.19 | 221.19 | 221.19 | 146.02 | 42.34 |
Retained Earnings | - | 363.24 | 205.57 | 223.5 | 147.38 | 110.4 |
Comprehensive Income & Other | - | 0.24 | 0.18 | - | - | - |
Total Common Equity | 866.69 | 785.18 | 627.47 | 544.96 | 385.07 | 213.42 |
Minority Interest | - | - | - | - | 0.01 | 0 |
Shareholders' Equity | 866.69 | 785.18 | 627.47 | 544.96 | 385.08 | 213.42 |
Total Liabilities & Equity | - | 978.43 | 844.56 | 694.65 | 556.16 | 437.07 |
Total Debt | 276.43 | 148.36 | 143.24 | 115.99 | 128.39 | 115.67 |
Net Cash (Debt) | -270.56 | -145.88 | -132.26 | -114.1 | -127.9 | -114.33 |
Net Cash Per Share | -13.48 | -7.28 | -6.60 | -5.92 | -10.45 | -7.85 |
Filing Date Shares Outstanding | 20.11 | 20.05 | 20.05 | 20.05 | 18.33 | 14.56 |
Total Common Shares Outstanding | 20.11 | 20.05 | 20.05 | 20.05 | 18.33 | 14.56 |
Working Capital | - | 703.88 | 542.29 | 476.16 | 345.54 | 200.43 |
Book Value Per Share | 43.18 | 39.16 | 31.29 | 27.18 | 21.00 | 14.65 |
Tangible Book Value | 866.69 | 785.18 | 627.47 | 544.96 | 385.07 | 213.42 |
Tangible Book Value Per Share | 43.18 | 39.16 | 31.29 | 27.18 | 21.00 | 14.65 |
Land | - | - | 4.17 | - | - | - |
Buildings | - | 90.9 | 45.49 | - | - | - |
Machinery | - | 54.43 | 53.43 | - | - | - |
Construction In Progress | - | - | 37.78 | - | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.